Lungenkarzinom Screening mit Niedrigdosis-CT: Stellungnahme der Österreichischen Röntgengesellschaft und der Österreichischen Gesellschaft für Pneumologie

Translated title of the contribution: Low dose CT screening for lung cancer: A statement of the Austrian Society of Radiology and the Austrian Society of Pneumology

Helmut Prosch, Michael Studnicka, Edith Eisenhuber, Horst Olschewski, Elisabeth Stiefsohn, Sylvia Hartl, Christian Herold, Otto Burghuber, Gerhard Mostbeck

Research output: Contribution to journalArticle

Abstract

The National Lung Screening Trial (NLST) could demonstrate, for the first time, in a prospective randomized trial, that low-dose CT screening (LD-CT) may decrease lung cancer mortality. At the moment, it is unclear how these results will be applicable to Austria. Specifically, the definition of the population at an increased risk for lung cancer and management of the high rate of false-positive results are problematic. As a consequence, lung cancer screening in Austria is recommended following the guidelines of the Austrian Society of Radiology and the Austrian Society of Pneumology. The recommendations suggest that only individuals with a significantly increased risk for lung cancer should be screened (age > 55 years, 30 pack-years, active or former smokers since < 15 years). The screened individuals must be informed about the high probability of false-positive screening results and the necessity for additional follow-up examinations or invasive examinations. The screened individuals must be informed that a CT screening may not prevent them from developing an inoperable lung cancer. In addition, CT screening examinations should be performed with a low-dose CT technique for at least three years at yearly intervals. In view of the high probability of false-positive findings, the evaluation of detected pulmonary nodules should be performed according to an already established standardized protocol.

Original languageGerman
Pages (from-to)339-345
Number of pages7
JournalWiener Klinische Wochenschrift
Volume125
Issue number11-12
DOIs
StatePublished - Jun 1 2013

    Fingerprint

Keywords

  • Consensus
  • Lung cancer
  • Screening

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prosch, H., Studnicka, M., Eisenhuber, E., Olschewski, H., Stiefsohn, E., Hartl, S., Herold, C., Burghuber, O., & Mostbeck, G. (2013). Lungenkarzinom Screening mit Niedrigdosis-CT: Stellungnahme der Österreichischen Röntgengesellschaft und der Österreichischen Gesellschaft für Pneumologie. Wiener Klinische Wochenschrift, 125(11-12), 339-345. https://doi.org/10.1007/s00508-013-0356-9